Skip to main content
Contact Us
Subscribe
E-Edition
66°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Best of 2024
Archives
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Nanovibronix Inc
(NQ:
NAOV
)
0.6977
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Sep 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Nanovibronix Inc
< Previous
1
2
3
Next >
NanoVibronix Announces Reverse Stock Split
February 08, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Provides Update on Expanding Access to PainShield
January 18, 2023
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces Results of Annual Meeting of Stockholders Held Today
December 15, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces Partnership with Peak Medical, Ltd.
December 13, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces Closing of $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
December 01, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 29, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Receives FDA 510(k) Premarket Clearance for PainShield Plus
November 28, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces Interim Results of Clinical Study for UroShield
November 16, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Provides Business Update in Letter to Shareholders
November 15, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Receives Extension to Satisfy Nasdaq Price Requirement
October 19, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix UroShield Approved for Sale through NHS Internal Supply Chain Contract
September 23, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Sets Date for Annual Shareholder Meeting
September 14, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces Distribution of Series F Preferred Stock to Holders of its Common Stock
September 14, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces Receipt of Nasdaq Listing Determination; Company to Request Hearing
September 02, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Provides Business Update in Letter to Shareholders
August 18, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces Webinar Series to Promote UroShield
July 12, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Strengthening Supply Chain Increasing Efficiency and Scalability
June 29, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Reports First Quarter 2022 Financial Results
May 17, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces FDA 510(k) Submission for PainShield® MD PLUS
May 04, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Adds Additional Product to Federal Supply Schedule
April 25, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Advances Efforts to Achieve NHS Approval
April 05, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces PainGuard and UroGuard Approved by Health Canada as Licensed Medical Devices
March 30, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Added an Additional National Payer Network in Workers’ Compensation Market
February 07, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Extends Reach of UroShield and PainShield through MTSG’s International Network
January 24, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Files Three U.S. Patent Applications Further Leveraging Its Innovative Surface Acoustic Wave Technology
January 19, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Expands Board of Directors with Appointment of Two New Independent Directors
January 13, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix to Present at the H.C. Wainwright BioConnect Virtual Conference
January 07, 2022
From
NanoVibronix Inc.
Via
Business Wire
NanoVibronix Further Expands VA Distribution Network to Include SDVOSB Delta Medical, LLC
January 06, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Selects Key Distributor to Exclusively Distribute PainShield for Veterans Administration Facilities
January 05, 2022
From
NanoVibronix, Inc.
Via
Business Wire
NanoVibronix Announces Agreement With Medina Healthcare Limited for Distribution of UroShield® and PainShield® in European Market Expansion
December 21, 2021
From
NanoVibronix Inc.
Via
Business Wire
< Previous
1
2
3
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.